Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amgen “Off To Strong Start” Under ASP Reimbursement System

This article was originally published in The Pink Sheet Daily

Executive Summary

“As each day goes by, we feel better” about ASP-based reimbursement for Medicare Part B drugs, CEO Sharer says. CMS’ “quality of care” demonstration project helps Amgen’s first quarter performance, resulting in increased guidance for 2005. Company execs predict the demo program will continue into 2006 due to “strong lobbying.”
Advertisement

Related Content

CMS Cancer "Quality Of Care" Data Show "A Lot Of Variations," McClellan Says
CMS Cancer "Quality Of Care" Data Show "A Lot Of Variations," McClellan Says
Medicare Cancer Demo May Encourage Use Of EPO, Anti-Emetics
Medicare Cancer Demo May Encourage Use Of EPO, Anti-Emetics
J&J Draws Line On Procrit Pricing; Will Not Match Amgen Aranesp 40% Discounts

Topics

Advertisement
UsernamePublicRestriction

Register

PS062055

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel